Efficacy and Safety of Surgical Treatment for Type IVa CBD

Summary

This study is a multicenter, bidirectional cohort study aimed at continuously enrolling patients with biliary dilatation from 25 medical centers in China. It will collect comprehensive life-cycle data from the cohort to establish a Chinese cohort for IVa biliary dilatation (BD). Based on this cohort, the study seeks to compare the perioperative risks, long-term outcomes, and quality of life of type IVa BD following surgical treatment, to establish standardized surgical treatment strategies for type IVa BD.

Eligibility

Inclusion Criteria:

1. Patients who have been diagnosed with Todani type IVa BD.
2. Patients aged between 0 and 80 years old, regardless of gender.
3. First-time receipt of surgery.

Exclusion Criteria:

1. With abnormal intrapancreatic bile duct
2. Inappropriate Roux-loop length (outside the range of 40-60 cm for adults and 15-30 cm for children)
3. With non-relevant surgical interventions
4. Pathologically confirmed carcinogenesis
5. Unresolved choledocholithiasis, bile duct stenosis, and Intrahepatic bile duct stones during the procedure.
6. Unavailable follow-up information.

Conditions2

Browse More Trials